Prium workers comp program targets inappropriate medications

Medical cost management services provider Prium, a unit of Ameritox Ltd., has launched a return-on-investment guarantee for its workers compensation medical intervention services to reduce the use of inappropriate medications.

Prium said it tested the return-on-investment guarantee in a two-year pilot program and quarterly reports showed savings from discontinuing or reducing inappropriate medications, the Duluth, Ga.-based services provider said Wednesday in a statement. “When compared to the cost of PRIUM's services, the aggregate ROI (actual medication cost savings versus PRIUM's fees) consistently exceeded three to one,” the statement said.

If the payers in the ROI program do not attain the agreed-upon ROI on a book of claims then they will get a refund of the portion of fees paid to achieve the guaranteed return, according to the statement.

“We're comfortable offering an ROI because Prium and its parent company, Ameritox, own the services involved in our integrated medical intervention approach,” President Michael Gavin said in a statement. “This gives us the ability to ensure that appropriate methodologies are used to enact the changes needed to help injured workers regain function.”

To participate in the guarantee, payers must use Prium and Ameritox services, according to the statement.